Detection_NN
of_IN
the_DT
chromosome_NN
16_CD
CBF_NN
beta-MYH11_NN
fusion_NN
transcript_NN
in_IN
myelomonocytic_JJ
leukemias_NNS
._.

Karyotypic_JJ
detection_NN
of_IN
chromosomal_JJ
16_CD
abnormalities_NNS
classically_RB
associated_VBN
with_IN
AML_NN
M4Eo_NN
can_MD
be_VB
difficult_JJ
._.

Characterization_NN
of_IN
the_DT
two_CD
genes_NNS
involved_VBN
in_IN
the_DT
inv_NN
16_CD
-LRB-_-LRB-
p13q22_NN
-RRB-_-RRB-
,_,
CBF_NN
beta_NN
and_CC
MYH11_NN
,_,
has_VBZ
allowed_VBN
the_DT
detection_NN
of_IN
fusion_NN
transcripts_NNS
by_IN
reverse-transcriptase_NN
polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
RT-PCR_NN
-RRB-_-RRB-
._.

We_PRP
have_VBP
analyzed_VBN
CBF_NN
beta-MYH11_NN
fusion_NN
transcripts_NNS
by_IN
RT-PCR_NN
in_IN
myelomonocytic_JJ
leukemias_NNS
,_,
with_IN
or_CC
without_IN
eosinophilia_NN
,_,
to_TO
determine_VB
whether_IN
their_PRP$
presence_NN
correlates_VBZ
with_IN
morphology_NN
._.

Fifty-three_CD
cases_NNS
-LRB-_-LRB-
11_CD
AML_NN
M4Eo_NN
;_:
1_CD
AML_NN
M4_NN
with_IN
atypical_JJ
abnormal_JJ
eosinophils_NNS
-LRB-_-LRB-
AML_NN
M4_NN
``_NN
Eo_NN
''_NN
-RRB-_-RRB-
;_:
29_CD
AML_NN
M4_NN
;_:
8_CD
AML_NN
M5_NN
;_:
3_CD
CMML_NN
;_:
and_CC
1_CD
AML_NN
M2_NN
with_IN
eosinophilia_NN
-RRB-_-RRB-
were_VBD
analyzed_VBN
._.

All_DT
11_CD
typical_JJ
AML_NN
M4Eo_NN
were_VBD
CBF_NN
beta-MYH11_NN
positive_JJ
._.

The_DT
single_JJ
case_NN
of_IN
AML_NN
M4_NN
with_IN
distinctive_JJ
eosinophil_NN
abnormalities_NNS
was_VBD
negative_JJ
by_IN
karyotype_NN
,_,
RT-PCR_NN
and_CC
fluorescent_JJ
in_FW
situ_FW
hybridization_NN
-LRB-_-LRB-
FISH_NN
-RRB-_-RRB-
._.

Three_CD
of_IN
29_CD
-LRB-_-LRB-
10_CD
%_NN
-RRB-_-RRB-
AML_NN
M4_NN
without_IN
abnormal_JJ
eosinophils_NNS
were_VBD
CBF_NN
beta-MYH11_NN
positive_JJ
,_,
1_CD
of_IN
which_WDT
did_VBD
not_RB
show_VB
any_DT
apparent_JJ
chromosome_NN
16_CD
abnormalities_NNS
by_IN
classical_JJ
metaphase_NN
analysis_NN
-LRB-_-LRB-
2_CD
not_RB
tested_VBN
-RRB-_-RRB-
._.

Both_DT
cases_NNS
tested_VBN
also_RB
showed_VBD
MYH11_NN
genomic_JJ
rearrangement_NN
._.

None_NN
of_IN
the_DT
other_JJ
leukemias_NNS
were_VBD
RT-PCR_NN
positive_JJ
._.

Follow-up_NN
of_IN
three_CD
patient_NN
showed_VBD
residual_JJ
positivity_NN
in_IN
apparent_JJ
complete_JJ
remission_NN
._.

These_DT
data_NNS
show_VBP
that_IN
CBF_NN
beta-MYH11_NN
fusion_NN
transcripts_NNS
occur_VBP
not_RB
only_RB
in_IN
the_DT
vast_JJ
majority_NN
of_IN
typical_JJ
AML_NN
M4Eo_NN
,_,
but_CC
also_RB
in_IN
approximately_RB
10_CD
%_NN
of_IN
AML_NN
M4_NN
without_IN
eosinophilic_JJ
abnormalities_NNS
,_,
a_DT
much_RB
higher_JJR
incidence_NN
than_IN
the_DT
sporadic_JJ
reports_NNS
of_IN
chromosome_NN
16_CD
abnormalities_NNS
in_IN
AML_NN
M4_NN
would_MD
suggest_VB
._.

Taken_VBN
together_RB
with_IN
the_DT
detection_NN
of_IN
CBF_NN
beta-MYH11_NN
transcripts_NNS
in_IN
the_DT
absence_NN
of_IN
apparent_JJ
chromosome_NN
16_CD
abnormalities_NNS
by_IN
classical_JJ
banding_NN
techniques_NNS
,_,
these_DT
data_NNS
show_VBP
that_IN
additional_JJ
screening_NN
by_IN
either_CC
RT-PCR_NN
or_CC
FISH_NN
should_MD
be_VB
performed_VBN
in_IN
all_DT
AML_NN
M4_NN
,_,
regardless_RB
of_IN
morphologic_JJ
features_NNS
,_,
to_TO
allow_VB
accurate_JJ
evaluation_NN
of_IN
the_DT
prognostic_JJ
importance_NN
of_IN
this_DT
fusion_NN
transcript_NN
._.

